Clinical Trial Update: Optimal Cardiac Resynchronization Therapy Pacing Rate [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the optimal pacing rate for cardiac resynchronization therapy in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Cardiac Resynchronization Therapy, Heart Failure | EARLY_Phase 1 | Status: COMPLETED